Novavax stock doubles after Sanofi deal marks 'new chapter' for company Yahoo FinanceNovavax shares spike over 100% on Sanofi deal to commercialize Covid vaccine, develop combination shots CNBCNovavax shares more than double on Sanofi’s $1.4 billion investment for combo vaccine MarketWatchNovavax (NVAX) Shares Soar on $1.2 Billion Sanofi Vaccine Licensing Deal BloombergNovavax strikes $1.2 billion deal with Sanofi in major turnaround Axios